Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy?
Ruth Warren(University of Cambridge), William Hollingworth(At Bristol), G.C. Wishart(Addenbrooke's Hospital), John R. Benson(Addenbrooke's Hospital), Helena Earl(University of Cambridge), Lynda G. Bobrow, Deepa Gopalan(Addenbrooke's Hospital), P.D. Britton(Addenbrooke's Hospital), Arnie Purushotham(King's College London)
Cited by 91
Related Papers
The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes
|Nature Communications|2016|1.8k
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
|The Lancet|2010|1.6k
A Randomized Trial of Vertebroplasty for Osteoporotic Spinal Fractures
|New England Journal of Medicine|2009|1.4k
Model Transparency and Validation
|Medical Decision Making|2012|803
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
|European Journal of Heart Failure|2020|767